F-star Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
ARMISTICE CAPITAL, LLC | 02/14/2023 | 1.00 M | $6.32 M | 100.00% | 4.58% |
ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/14/2023 | 751,889 | $4.75 M | 0.00% | 3.44% |
TRIUM CAPITAL LLP | 01/31/2023 | 679,744 | $4.30 M | 100.00% | 3.11% |
ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC | 02/14/2023 | 599,524 | $3.79 M | 0.00% | 2.74% |
DAFNA CAPITAL MANAGEMENT LLC | 02/14/2023 | 576,881 | $3.65 M | 0.00% | 2.64% |
ATLAS VENTURE ADVISORS, INC. | 01/31/2023 | 574,996 | $3.63 M | 0.00% | 2.63% |
WEISS ASSET MANAGEMENT LP | 02/14/2023 | 548,189 | $3.46 M | 100.00% | 2.51% |
BALYASNY ASSET MANAGEMENT L.P. | 02/14/2023 | 502,800 | $3.18 M | 100.00% | 2.30% |
RUSSELL INVESTMENTS GROUP, LTD. | 02/08/2023 | 432,125 | $2.73 M | -11.94% | 1.98% |
CRYSTALLINE MANAGEMENT INC. | 03/13/2023 | 375,000 | $2.37 M | 100.00% | 1.72% |
BLACKROCK INC. | 02/13/2023 | 297,433 | $1.88 M | -0.12% | 1.36% |
VANGUARD GROUP INC | 02/10/2023 | 292,664 | $1.85 M | -6.38% | 1.34% |
BARCLAYS PLC | 02/13/2023 | 226,433 | $1.43 M | 0.00% | 1.04% |
CITIGROUP INC | 02/09/2023 | 206,400 | $1.30 M | 0.00% | 0.94% |
GABELLI FUNDS LLC | 02/13/2023 | 204,651 | $1.29 M | 6.38% | 0.94% |
GEODE CAPITAL MANAGEMENT, LLC | 02/13/2023 | 185,982 | $1.18 M | 0.00% | 0.85% |
QUINN OPPORTUNITY PARTNERS LLC | 02/14/2023 | 179,705 | $1.14 M | 100.00% | 0.82% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2023 | 171,911 | $1.09 M | -22.39% | 0.79% |
MURCHINSON LTD. | 02/10/2023 | 166,906 | $1.05 M | 2.63% | 0.76% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2023 | 144,700 | $914,504 | -40.84% | 0.66% |
GABELLI & CO INVESTMENT ADVISERS, INC. | 02/15/2023 | 142,110 | $898,135 | -3.39% | 0.65% |
BCK CAPITAL MANAGEMENT LP | 02/09/2023 | 137,459 | $868,741 | 164.34% | 0.63% |
VAZIRANI ASSET MANAGEMENT LLC | 02/14/2023 | 125,000 | $790,000 | 100.00% | 0.57% |
GOLDMAN SACHS GROUP INC | 05/14/2024 | 104,690 | $661,641 | 41.27% | 0.48% |
JANE STREET GROUP, LLC | 02/15/2023 | 98,099 | $619,986 | -27.94% | 0.45% |
BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2023 | 83,454 | $527,429 | 2.63% | 0.38% |
STATE STREET CORP | 05/15/2023 | 67,950 | $429,444 | 0.00% | 0.31% |
PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2023 | 63,047 | $398,000 | 0.00% | 0.29% |
PRELUDE CAPITAL MANAGEMENT, LLC | 02/14/2023 | 60,807 | $384,300 | 218.56% | 0.28% |
TOROSO INVESTMENTS, LLC | 02/15/2023 | 55,400 | $350,000 | -11.33% | 0.25% |
FORMIDABLE ASSET MANAGEMENT, LLC | 02/07/2023 | 55,366 | $350,000 | -11.38% | 0.25% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2023 | 55,066 | $348,017 | -48.41% | 0.25% |
TLS ADVISORS LLC | 02/14/2023 | 54,298 | $343,000 | 100.00% | 0.25% |
BANK OF NEW YORK MELLON CORP | 02/14/2023 | 53,122 | $335,731 | -0.58% | 0.24% |
CONNOLLY SARAH T. | 02/09/2023 | 53,001 | $334,966 | 0.00% | 0.24% |
RIDGEBACK CAPITAL INVESTMENTS L.P. | 02/14/2023 | 52,509 | $331,857 | 100.00% | 0.24% |
WOLVERINE ASSET MANAGEMENT LLC | 02/01/2023 | 51,101 | $322,958 | 8.81% | 0.23% |
BROOKFIELD CORP /ON/ | 02/14/2023 | 50,000 | $316,000 | 100.00% | 0.23% |
PRELUDE CAPITAL MANAGEMENT, LLC | 02/14/2023 | 49,600 | $313,472 | 100.00% | 0.23% |
FAIRFAX FINANCIAL HOLDINGS LTD/ CAN | 02/14/2023 | 49,399 | $311,708 | 102.46% | 0.23% |
MAN GROUP PLC | 02/14/2023 | 42,411 | $268,038 | 100.00% | 0.19% |
NORTHERN TRUST CORP | 02/13/2023 | 35,102 | $221,845 | 0.00% | 0.16% |
ANSON FUNDS MANAGEMENT LP | 02/13/2023 | 30,000 | $189,600 | 100.00% | 0.14% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2023 | 27,600 | $174,432 | 100.00% | 0.13% |
SHAY CAPITAL LLC | 02/14/2023 | 23,456 | $148,242 | 100.00% | 0.11% |
PENDERFUND CAPITAL MANAGEMENT LTD. | 02/10/2023 | 22,760 | $195,000 | -13.59% | 0.10% |
MILLENNIUM MANAGEMENT LLC | 02/14/2023 | 18,645 | $118,000 | 54.10% | 0.09% |
SQUAREPOINT OPS LLC | 02/14/2023 | 14,888 | $94,092 | -20.36% | 0.07% |
HUNTING HILL GLOBAL CAPITAL, LLC | 02/14/2023 | 14,767 | $93,327 | -44.90% | 0.07% |
VIRTU FINANCIAL LLC | 02/15/2023 | 13,933 | $88,000 | 100.00% | 0.06% |
F-star Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 2 institutional investors and hedge funds held shares of F-star Therapeutics, Inc.. The most heavily invested institutionals were:
S. MUOIO & CO. LLC: 40,000
Urban Wealth Management, LLC: 4,691
41.84% of F-star Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 44,691 shares in the last 24 months. This purchase volume represents approximately $318,200 in transactions.